Top Biotechnology companies in Netherlands by EBIT

This ranking features the top 6 Biotechnology companies in Netherlands ranked by EBIT, totaling a EBIT of USD -636.73 M, for July 24, 2025.

#	Name	Market Capitalization Share Price Year-To-Date (YTD) return Price to Earnings Ratio (P/E) Revenue Revenue Year-on-Year (YoY) growth Operating Income EBITDA Free Cash Flow Dividend Yield Free Cash Flow Yield Total Assets Total Liabilities Cash and Short-Term Investments	Stock Price	Change	Price (30 days)	52W low/high	Sector

Items per page

Frequently Asked Questions

Which Biotechnology company in Netherlands has the highest EBIT ?

The Biotechnology company in Netherlands with the highest EBIT is Qiagen N.V. (NYSE: QGEN) at USD 179.25 M.

Which Biotechnology company in Netherlands has the lowest EBIT ?

The Biotechnology company in Netherlands with the lowest EBIT is Merus N.V. (NasdaqGM: MRUS) at USD -340.33 M.

What are the top 10 Biotechnology companies in Netherlands by EBIT ?

The top 10 Biotechnology companies in Netherlands by EBIT are Qiagen N.V., LAVA Therapeutics N.V., ProQR Therapeutics N.V., uniQure N.V., NewAmsterdam Pharma Company N.V. and Merus N.V..

What are the bottom 10 Biotechnology companies in Netherlands by EBIT ?

The bottom 10 Biotechnology companies in Netherlands by EBIT are Merus N.V., NewAmsterdam Pharma Company N.V., uniQure N.V., ProQR Therapeutics N.V., LAVA Therapeutics N.V. and Qiagen N.V..